Michael J. Finn's most recent trade in Vaxart Inc was a trade of 95,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 16,000 | 702,840 (1%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,073 | 5,313 (0%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.29 per share. | 10 Nov 2024 | 339 | 4,240 (0%) | 0% | 86.3 | 29,252 | Common Stock |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 16,000 | 686,840 (1%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 44,224 | 44,224 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 7,375 | 670,840 (1%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 1,322 | 3,817 (0%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.67 per share. | 13 Nov 2022 | 73 | 2,495 (0%) | 0% | 81.7 | 5,962 | Common Stock |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Purchase of securities on an exchange or from another person at price $ 88.88 per share. | 31 Aug 2022 | 8 | 2,576 (0%) | 0% | 88.9 | 711 | Common Stock |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Purchase of securities on an exchange or from another person at price $ 87.67 per share. | 31 Aug 2022 | 6 | 3,831 (0%) | 0% | 87.7 | 526 | Common Stock |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 44,224 | 44,224 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 7,375 | 663,465 (1%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.59 per share. | 15 Nov 2021 | 116 | 2,568 (0%) | 0% | 87.6 | 10,160 | Common Stock |
| Sanfilippo (John B.) & Son... | Michael J. Finn | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2021 | 1,261 | 2,684 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Michael J. Finney | Director | 18 Jun 2021 | 181,818 | 0 | - | - | Common Stock Purchase Warrant | ||
| Vaxart Inc | Michael J. Finney | Director | 18 Jun 2021 | 181,818 | 656,090 (1%) | 0% | 1.1 | 200,000 | Common Stock | |
| Vaxart Inc | Michael J. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 18 Jun 2021 | 12,700 | 474,272 (0%) | 0% | 0.7 | 8,636 | Common Stock |
| Vaxart Inc | Michael J. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2021 | 12,700 | 0 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 18 Jun 2021 | 9,000 | 461,572 (0%) | 0% | 0.7 | 6,120 | Common Stock |
| Vaxart Inc | Michael J. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2021 | 9,000 | 0 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Michael J. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,097 | 15,097 | - | - | Stock Option (right to buy) |